FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

De Novo OK for Osteopenia Device

FDA grants Bone Health Technologies a de novo marketing authorization for its Osteoboost, the first non-pharmacological device-based prescription trea...

latest-news-card-1
Human Drugs

Gilead Trodelvy Trial Misses Endpoint

Gilead Sciences says its Trodelvy Phase 3 EVOKE-01 study did not meet its primary endpoint of overall survival in previously treated patients with met...

Medical Devices

Kallisio Oral Stent Cleared

FDA clears a Kallisio 510(k) for Stentra, a 3D-printed oral stent designed to protect healthy tissue in head and neck cancer patients.

latest-news-card-1
Federal Register

Info Collection on Rx Drug Marketing

Federal Register notice: FDA seeks comments on an information collection extension entitled Prescription Drug Marketing: Administrative Procedures, Po...

latest-news-card-1
Federal Register

Qulipta Approval Used Priority Voucher

Federal Register notice: FDA announces that Abbvies Qulipta was approved using a material threat medical countermeasure priority review voucher.

latest-news-card-1
Medical Devices

Panel to Vote on Abbott TriClip PMA

Federal Register notice: FDA announces a 2/13 meeting of its Medical Devices Advisory Committees Circulatory System Devices Panel that will vote on an...

latest-news-card-1
Human Drugs

Lilly Inspection Cites 8 Findings: Report

A 7/2023 inspection of Eli Lillys Branchburg, NJ cites eight GMP deficiencies, according to inspection documents referenced in a Reuters report.

latest-news-card-1
Medical Devices

Globus Recalls Fluoroscopy Fixture Kit

Globus Medical recalls its ExcelsiusGPS Flat Panel Fluoroscopy Fixture Kit due to a calibration error.

latest-news-card-1
Biologics

Boxed Warning Added to Amgens Prolia

FDA adds a Boxed Warning to Amgens osteoporosis drug Prolia (denosumab) about increased risk of severe hypocalcemia in patients with advanced chronic ...

latest-news-card-1
Human Drugs

Klobuchar Targets Improper Patent Listings

Senator Amy Klobuchar (D-MN) sends letters to six pharmaceutical companies Abbvie, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan-Viatris,...